Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on May 15, 2007
Chest, doi:10.1378/chest.06-2731
A more recent version of this article appeared on July 1, 2007
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
chest.06-2731v1
132/1/58    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horonenko, G.
Right arrow Articles by Hayden, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horonenko, G.
Right arrow Articles by Hayden, J. M.

Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1) is increased in patients with ventilator-associated pneumonia: a preliminary report

Grigory Horonenko, D.O.; Jeffrey C. Hoyt, Ph.D.; Richard A. Robbins, M.D., F.C.C.P.; Clement U. Singarajah, M.D., F.C.C.P.; Alp Umar, M.D.; Jenny Pattengill, B.S. and John M. Hayden, Ph.D.

Carl T. Hayden VA Medical Center, Good Samaritan Regional Medical Center and the Arizona Respiratory Center, Phoenix, AZ

Richard.Robbins2{at}med.va.gov

Richard.Robbins2{at}med.va.gov

Abstract

RationaleThe diagnosis of ventilator-associated pneumonia can be difficult. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) has been reported to be elevated in bronchoalveolar lavage fluid from patients with ventilator-associated pneumonia (VAP). Objectives: To evaluate the utility sTREM-1 in the diagnosis of ventilator-associated pneumonia in bronchoalveolar lavage fluid and the fluid collected in the expiratory trap from the ventilator, exhaled ventilator condensate (EVC). Methods: We prospectively collected bronchoalveolar lavage fluid and EVC from 23 patients clinically suspected of VAP. A sensitive enzyme-linked immunosorbant assay was developed to measure sTREM-1. The results derived from this assay were confirmed using an immunoblot technique. The presence of VAP was clinically determined using the modified clinical pulmonary infection score of > 6. Results: Fourteen of 23 patients were diagnosed with VAP. sTREM-1 was detected in the EVC in 11 of 14 subjects with VAP but in only 1 of 9 subjects without ventilator-associated pneumonia and was significantly higher in the pneumonia patients and when expressed as pg/ml or pg/µg protein (p=0.005, both comparisons). In contrast, sTREM was detected in the bronchoalveolar lavage fluid of all 14 VAP subjects but also in of 8 of 9 subjects with no pneumonia and did not differ in the VAP subjects compared to the non-pneumonia subjects when expressed as pg/ml or pg/µg protein (p>0.05 both comparisons ). Conclusion: sTREM-1 is detectable in EVC and may be useful in establishing or excluding the diagnosis of VAP.

Key Words: ventilator-associated pneumonia • exhaled breath condensate • soluble triggering receptor expressed on myeloid cells-1 • bronchoalveolar lavage







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American College of Chest Physicians.